HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers

Autor: Jha, Sujeet, Batra, Nitish, Siddiqui, Samreen, Yadav, Ashutosh, Misra, Archa, Loomba, Menka, Sethi, Sumeet, Waghdhare, Swati
Zdroj: Indian Heart Journal; January-February 2021, Vol. 73 Issue: 1 p74-76, 3p
Abstrakt: HCQ is a commonly recommended drug for the prophylaxis of COVID-19. One of its rare side-effect includes QTc prolongation.
Databáze: Supplemental Index